October 10, 2024

Harmony Thrive

Superior Health, Meaningful Life

Cure51 co-founders on changing cancer treatment

Cure51 co-founders on changing cancer treatment

In this exclusive interview, they share insights into their mission to decode exceptional cancer survival cases, their innovative methodologies, and future plans to transform oncology.

Can you tell us more about the founding story of Cure51 and what inspired you to start this venture?

Cure51 was founded on the principle that the answers to some of our most challenging medical questions, particularly cancer, might already exist in the experiences of outlier patients, in other words, in the realm of nature. We have combined expertise in entrepreneurship, AI and biotech and this creates a unique synergy helping us build Cure51. We are on a mission to track, analyze, and understand these exceptional cases. The inspiring stories of patients who beat the odds drove us to delve deeper into what made their recoveries possible and bring their superbiology to all patients.

How did your backgrounds in AI and biotech contribute to the creation and mission of Cure51?

Nicolas already built and scaled a healthtech company, Qare. He comes with firsthand business building expertise in the sector, as well as an understanding of AI’s potential to analyze complex data patterns. Simon’s techbio background, notably through the advisory role he held at Owkin, the leading french-american AI biotech, and its crucial role in creating Resilience, a remote patient monitoring app in oncology, provided the necessary insights into biological processes and clinical research. Together, we created a platform that leverages AI to analyze the genetic, molecular, and clinical landscape of cancer survivors, aiming to uncover patterns and mechanisms that traditional research might overlook.

link

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | Newsphere by AF themes.